Skip to main content
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

Health App Directory has been online for one year in Germany: facts and numbers

The application portal for inclusion in the Health App Directory at the Federal Office for Drugs and Medical Devices (BfArM) in Germany has been online since May 27, 2020. The first reimbursable health apps were introduced on the Directory in early October 2020.

The manufacturer applies for the reimbursement (inclusion of the app on the Health App Directory) using the application form to the BfArM. If the manufacturer cannot immediately prove the benefit, but the method is promising and has the potential to prove benefits, a testing trial with a temporary listing in the Directory can be activated on application from a manufacturer (Fast Track procedure).

As of May 27, 2021, a total of 74 applications were received, 51 (69%) of which for provisional listing and 23 (31%) for final listing. Fifteen applications (20%) were introduced on the Directory, the negative decision was made for four applications (5%), 31 applications (42%) were withdrawn, and 24 (32%) are currently being processed.

The full details in German can be found here.

This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news).

Not ready for a subscription service? Subscribe to our free-of-charge newsletter delivered every second week to get updates about key reimbursement developments in Europe (10-12 news every two weeks). First EU issues of both newsletters are available for download free-of-charge.